{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:58:06Z","timestamp":1793699886775,"version":"4.5.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T00:00:00Z","timestamp":1493769600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Clinical Research Project of Huai\u2019an Technology Project Bureau","award":["HAS2011023"],"award-info":[{"award-number":["HAS2011023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Trace Elem Res"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s12011-017-1039-6","type":"journal-article","created":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T05:38:21Z","timestamp":1493789901000},"page":"22-30","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Association of Serum Trace Elements with Schizophrenia and Effects of Antipsychotic Treatment"],"prefix":"10.1007","volume":"181","author":[{"given":"Xuefei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingshui","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,3]]},"reference":[{"issue":"10","key":"1039_CR1","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S1474-4422(04)00869-5","volume":"3","author":"J Bradbury","year":"2004","unstructured":"Bradbury J (2004) Schizophrenia molecular pathway emerges. The Lancet Neurology 3(10):574","journal-title":"The Lancet Neurology"},{"issue":"5","key":"1039_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0020141","volume":"2","author":"S Saha","year":"2005","unstructured":"Saha S, Chant D, Welham J, McGrath J (2005) A systematic review of the prevalence of schizophrenia. PLoS Med 2(5):e141. doi:\n10.1371\/journal.pmed.0020141","journal-title":"PLoS Med"},{"issue":"9904","key":"1039_CR3","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/s0140-6736(13)61611-6","volume":"382","author":"HA Whiteford","year":"2013","unstructured":"Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, Charlson FJ, Norman RE, Flaxman AD, Johns N, Burstein R, Murray CJL, Vos T (2013) Global burden of disease attributable to mental and substance use disorders: findings from the global burden of disease study 2010. Lancet 382(9904):1575\u20131586. doi:\n10.1016\/s0140-6736(13)61611-6","journal-title":"Lancet"},{"issue":"2","key":"1039_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/YCO.0b013e32835035ca","volume":"25","author":"TM Laursen","year":"2012","unstructured":"Laursen TM, Munk-Olsen T, Vestergaard M (2012) Life expectancy and cardiovascular mortality in persons with schizophrenia. Current opinion in psychiatry 25(2):83\u201388. doi:\n10.1097\/YCO.0b013e32835035ca","journal-title":"Current opinion in psychiatry"},{"issue":"2","key":"1039_CR5","first-page":"89","volume":"106","author":"R Tandon","year":"2008","unstructured":"Tandon R, Keshavan MS, Nasrallah HA (2008) Schizophrenia, \u201cJust the Facts\u201d: what we know in 2008 part 1: overview. Schizophr Res 106(2):89\u2013107","journal-title":"Schizophr Res"},{"issue":"10","key":"1039_CR6","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1016\/j.neubiorev.2013.04.010","volume":"37","author":"JM R\u00e9thelyi","year":"2013","unstructured":"R\u00e9thelyi JM, Benkovits J, Bitter I (2013) Genes and environments in schizophrenia: the different pieces of a manifold puzzle. Neurosci Biobehav Rev 37(10):2424\u20132437","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"1039_CR7","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.neuro.2006.12.001","volume":"28","author":"A Alimonti","year":"2007","unstructured":"Alimonti A, Ristori G, Giubilei F, Stazi MA, Pino A, Visconti A, Brescianini S, Sepe Monti M, Forte G, Stanzione P, Bocca B, Bomboi G, D'Ippolito C, Annibali V, Salvetti M, Sancesario G (2007) Serum chemical elements and oxidative status in Alzheimer\u2019s disease, Parkinson disease and multiple sclerosis. Neurotoxicology 28(3):450\u2013456. doi:\n10.1016\/j.neuro.2006.12.001","journal-title":"Neurotoxicology"},{"issue":"4\u20135","key":"1039_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.mam.2005.07.013","volume":"26","author":"CG Fraga","year":"2005","unstructured":"Fraga CG (2005) Relevance, essentiality and toxicity of trace elements in human health. Mol Asp Med 26(4\u20135):235\u2013244. doi:\n10.1016\/j.mam.2005.07.013","journal-title":"Mol Asp Med"},{"issue":"3","key":"1039_CR9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s12011-012-9371-3","volume":"148","author":"H Shohag","year":"2012","unstructured":"Shohag H, Ullah A, Qusar S, Rahman M, Hasnat A (2012) Alterations of serum zinc, copper, manganese, iron, calcium, and magnesium concentrations and the complexity of interelement relations in patients with obsessive-compulsive disorder. Biol Trace Elem Res 148(3):275\u2013280. doi:\n10.1007\/s12011-012-9371-3","journal-title":"Biol Trace Elem Res"},{"issue":"1\u20132","key":"1039_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cca.2008.04.003","volume":"394","author":"MS Mustak","year":"2008","unstructured":"Mustak MS, Rao TS, Shanmugavelu P, Sundar NM, Menon RB, Rao RV, Rao KS (2008) Assessment of serum macro and trace element homeostasis and the complexity of inter-element relations in bipolar mood disorders. Clinica chimica acta; international journal of clinical chemistry 394(1\u20132):47\u201353. doi:\n10.1016\/j.cca.2008.04.003","journal-title":"Clinica chimica acta; international journal of clinical chemistry"},{"issue":"3","key":"1039_CR11","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s12011-009-8441-7","volume":"133","author":"Z Nahar","year":"2010","unstructured":"Nahar Z, Azad MA, Rahman MA, Rahman MA, Bari W, Islam SN, Islam MS, Hasnat A (2010) Comparative analysis of serum manganese, zinc, calcium, copper and magnesium level in panic disorder patients. Biol Trace Elem Res 133(3):284\u2013290. doi:\n10.1007\/s12011-009-8441-7","journal-title":"Biol Trace Elem Res"},{"issue":"1","key":"1039_CR12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000255462","volume":"34","author":"T Fukushima","year":"2010","unstructured":"Fukushima T, Tan X, Luo Y, Kanda H (2010) Relationship between blood levels of heavy metals and Parkinson\u2019s disease in China. Neuroepidemiology 34(1):18\u201324. doi:\n10.1159\/000255462","journal-title":"Neuroepidemiology"},{"issue":"2","key":"1039_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/s0924-977x(02)00073-1","volume":"13","author":"M Kuloglu","year":"2003","unstructured":"Kuloglu M, Atmaca M, \u00dcst\u00fcndag B, Canatan H, Gecici O, Tezcan E (2003) Serum iron levels in schizophrenic patients with or without akathisia. Eur Neuropsychopharmacol 13(2):67\u201371. doi:\n10.1016\/s0924-977x(02)00073-1","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2","key":"1039_CR14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s12011-008-8230-8","volume":"127","author":"A Rahman","year":"2009","unstructured":"Rahman A, Azad MA, Hossain I, Qusar MM, Bari W, Begum F, Huq SM, Hasnat A (2009) Zinc, manganese, calcium, copper, and cadmium level in scalp hair samples of schizophrenic patients. Biol Trace Elem Res 127(2):102\u2013108. doi:\n10.1007\/s12011-008-8230-8","journal-title":"Biol Trace Elem Res"},{"issue":"5","key":"1039_CR15","doi-asserted-by":"crossref","first-page":"549S","DOI":"10.1080\/07315724.2004.10719401","volume":"23","author":"M Nechifor","year":"2004","unstructured":"Nechifor M, Vaideanu C, Palamaru I, Borza C, Mindreci I (2004) The influence of some antipsychotics on erythrocyte magnesium and plasma magnesium, calcium, copper and zinc in patients with paranoid schizophrenia. J Am Coll Nutr 23(5):549S\u2013551S","journal-title":"J Am Coll Nutr"},{"issue":"2","key":"1039_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1385\/BTER:98:2:109","volume":"98","author":"M Yanik","year":"2004","unstructured":"Yanik M, Kocyigit A, Tutkun H, Vural H, Herken H (2004) Plasma manganese, selenium, zinc, copper, and iron concentrations in patients with schizophrenia. Biol Trace Elem Res 98(2):109\u2013117. doi:\n10.1385\/BTER:98:2:109","journal-title":"Biol Trace Elem Res"},{"issue":"1","key":"1039_CR17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0165-1781(00)00126-8","volume":"94","author":"A Herr\u00e1n","year":"2000","unstructured":"Herr\u00e1n A, Garc\u00eda-Unzueta MT, Fern\u00e1ndez-Gonz\u00e1lez MD, V\u00e1zquez-Barquero JL, Alvarez C, Amado JA (2000) Higher levels of serum copper in schizophrenic patients treated with depot neuroleptics. Psychiatry Res 94(1):51\u201358","journal-title":"Psychiatry Res"},{"issue":"3","key":"1039_CR18","first-page":"231","volume":"4","author":"AG Alias","year":"1972","unstructured":"Alias AG, Vijayan N, Nair DS, Sukumaran M (1972) Serum ceruloplasmin in schizophrenia: significant increase in acute cases especially in catatonia. Biol Psychiatry 4(3):231\u2013238","journal-title":"Biol Psychiatry"},{"issue":"127","key":"1039_CR19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1192\/bjp.127.2.119","volume":"127","author":"DA Olatunbosun","year":"1975","unstructured":"Olatunbosun DA, Akindele MO, Adadevoh BK, Asuni T (1975) Serum copper in schizophrenia in Nigerians. British Journal of Psychiatry the Journal of Mental Science 127(127):119\u2013121","journal-title":"British Journal of Psychiatry the Journal of Mental Science"},{"issue":"2","key":"1039_CR20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1385\/BTER:98:2:109","volume":"98","author":"M Yanik","year":"2004","unstructured":"Yanik M, Kocyigit A, Tutkun H, Vural H, Herken H (2004) Plasma manganese, selenium, zinc, copper, and iron concentrations in patients with schizophrenia. Biol Trace Elem Res 98(2):109\u2013117","journal-title":"Biol Trace Elem Res"},{"issue":"2","key":"1039_CR21","first-page":"289","volume":"7","author":"GA Asare","year":"2014","unstructured":"Asare GA, Tetteh R, Amedonu E, Asiedu B, Doku D (2014) Toxicity, deficiency and dysmetabolism of trace elements in Ghanaian clinically stable schizophrenics. Macedonian Journal of Medical Sciences 7(2):289\u2013294","journal-title":"Macedonian Journal of Medical Sciences"},{"key":"1039_CR22","doi-asserted-by":"crossref","first-page":"15013","DOI":"10.1038\/srep15013","volume":"5","author":"L Cai","year":"2015","unstructured":"Cai L, Chen T, Yang J, Zhou K, Yan X, Chen W, Sun L, Li L, Qin S, Wang P (2015) Serum trace element differences between schizophrenia patients and controls in the Han Chinese population. Scientific Reports 5:15013","journal-title":"Scientific Reports"},{"issue":"1","key":"1039_CR23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s12011-013-9842-1","volume":"156","author":"B Vidovi\u0107","year":"2013","unstructured":"Vidovi\u0107 B, \u0110or\u0111evi\u0107 B, Milovanovi\u0107 S, \u0160krivanj S, Pavlovi\u0107 Z, Stefanovi\u0107 A, Kotur-Stevuljevi\u0107 J (2013) Selenium, zinc, and copper plasma levels in patients with schizophrenia: relationship with metabolic risk factors. Biol Trace Elem Res 156(1):22","journal-title":"Biol Trace Elem Res"},{"key":"1039_CR24","doi-asserted-by":"crossref","unstructured":"Pfeiffer CC, Iliev V (1972) A study of zinc deficiency and copper excess in the schizophrenias. International Review of Neurobiology:141\u2013165","DOI":"10.1016\/B978-0-12-366851-6.50012-0"},{"key":"1039_CR25","unstructured":"Ogundahunsi OA, Duduyemi OO, OO S (2011) Effects of antipsychotic drugs on the levels of selected trace elements in schizophrenia. Afr Sci 12:77\u201382"},{"issue":"2","key":"1039_CR26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jtemb.2004.09.003","volume":"18","author":"ML Hegde","year":"2004","unstructured":"Hegde ML, Shanmugavelu P, Vengamma B, Rao TS, Menon RB, Rao RV, Rao KS (2004) Serum trace element levels and the complexity of inter-element relations in patients with Parkinson\u2019s disease. Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements 18(2):163\u2013171","journal-title":"Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements"},{"issue":"1","key":"1039_CR27","first-page":"1","volume":"15","author":"ME Naffaa","year":"2014","unstructured":"Naffaa ME, Mustafa M, Azzam M, Nasser R, Andria N, Azzam ZS, Braun E (2014) Serum inorganic phosphorus levels predict 30-day mortality in patients with community acquired pneumonia. BMC Infect Dis 15(1):1\u201310","journal-title":"BMC Infect Dis"},{"issue":"6","key":"1039_CR28","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3945\/an.113.004812","volume":"4","author":"OM Guti\u00e9rrez","year":"2013","unstructured":"Guti\u00e9rrez OM (2013) The connection between dietary phosphorus, cardiovascular disease, and mortality: where we stand and what we need to know. Adv Nutr 4(6):723\u2013729","journal-title":"Adv Nutr"},{"issue":"52","key":"1039_CR29","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","volume":"52","author":"F Tentori","year":"2008","unstructured":"Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, Young EW, Akizawa T, Akiba T, Pisoni RL (2008) Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 52(52):519\u2013530","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"1039_CR30","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1001\/archinte.167.9.879","volume":"167","author":"R Dhingra","year":"2007","unstructured":"Dhingra R, Sullivan LM, Fox CS, Wang TJ, D'Agostino RB, Gaziano JM, Vasan RS (2007) Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch intern med 167(9):879\u2013885. doi:\n10.1001\/archinte.167.9.879","journal-title":"Arch intern med"},{"issue":"1","key":"1039_CR31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0167-5273(97)02971-9","volume":"60","author":"R Narang","year":"1997","unstructured":"Narang R, Ridout D, Nonis C, Kooner JS (1997) Serum calcium, phosphorus and albumin levels in relation to the angiographic severity of coronary artery disease. Int J Cardiol 60(1):73\u201379","journal-title":"Int J Cardiol"},{"issue":"1","key":"1039_CR32","first-page":"43","volume":"44","author":"R Mehdi","year":"2006","unstructured":"Mehdi R, Asadollah Mohseni K (2006) Serum calcium and phosphorus associate with the occurrence and severity of angiographically documented coronary heart disease, possibly through correlation with atherogenic (apo)lipoproteins. Clinical Chemistry & Laboratory Medicine Cclm 44(1):43\u201350","journal-title":"Clinical Chemistry & Laboratory Medicine Cclm"},{"issue":"1","key":"1039_CR33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0165-1781(00)00126-8","volume":"94","author":"A Herran","year":"2000","unstructured":"Herran A, Garcia-Unzueta MT, Fernandez-Gonzalez MD, Vazquez-Barquero JL, Alvarez C, Amado JA (2000) Higher levels of serum copper in schizophrenic patients treated with depot neuroleptics. Psychiatry Res 94(1):51\u201358","journal-title":"Psychiatry Res"},{"issue":"1","key":"1039_CR34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0165-0173(03)00203-0","volume":"43","author":"MS Lidow","year":"2003","unstructured":"Lidow MS (2003) Calcium signaling dysfunction in schizophrenia: a unifying approach. Brain Res Brain Res Rev 43(1):70\u201384","journal-title":"Brain Res Brain Res Rev"},{"issue":"5","key":"1039_CR35","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0006-3223(96)00365-4","volume":"42","author":"M Maes","year":"1997","unstructured":"Maes M, Vandoolaeghe E, Neels H, Demedts P, Wauters A, Meltzer HY, Altamura C, Desnyder R (1997) Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune\/inflammatory response in that illness. Biol Psychiatry 42(5):349\u2013358","journal-title":"Biol Psychiatry"},{"issue":"3","key":"1039_CR36","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jad.2010.04.024","volume":"126","author":"M Siwek","year":"2010","unstructured":"Siwek M, Dudek D, Schlegel-Zawadzka M, Morawska A, Piekoszewski W, Opoka W, Zieba A, Pilc A, Popik P, Nowak G (2010) Serum zinc level in depressed patients during zinc supplementation of imipramine treatment. J Affect Disord 126(3):447\u2013452. doi:\n10.1016\/j.jad.2010.04.024","journal-title":"J Affect Disord"},{"issue":"2","key":"1039_CR37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0165-0327(94)90117-1","volume":"31","author":"M Maes","year":"1994","unstructured":"Maes M, D'Haese PC, Scharpe S, D'Hondt P, Cosyns P, De Broe ME (1994) Hypozincemia in depression. J Affect Disord 31(2):135\u2013140","journal-title":"J Affect Disord"},{"key":"1039_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/Srep15013","author":"L Cai","year":"2015","unstructured":"Cai L, Chen TL, Yang JL, Zhou KJ, Yan XM, Chen WZ, Sun LY, Li LL, Qin SY, Wang P, Yang P, Cui DH, Burmeister M, He L, Jia W, Wan CL (2015) Serum trace element differences between schizophrenia patients and controls in the Han Chinese population. Sci Rep-Uk 5. doi:\n10.1038\/Srep15013","journal-title":"Sci Rep-Uk"},{"issue":"2","key":"1039_CR39","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12011-008-8230-8","volume":"127","author":"A Rahman","year":"2009","unstructured":"Rahman A, Azad MA, Hossain I, Qusar MM, Bari W, Begum F, Huq SM, Hasnat A (2009) Zinc, manganese, calcium, copper, and cadmium level in scalp hair samples of schizophrenic patients. Biol Trace Elem Res 127(2):102\u2013108","journal-title":"Biol Trace Elem Res"},{"issue":"1","key":"1039_CR40","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00726-008-0195-6","volume":"36","author":"N Whittle","year":"2009","unstructured":"Whittle N, Lubec G, Singewald N (2009) Zinc deficiency induces enhanced depression-like behaviour and altered limbic activation reversed by antidepressant treatment in mice. Amino Acids 36(1):147\u2013158. doi:\n10.1007\/s00726-008-0195-6","journal-title":"Amino Acids"},{"issue":"2","key":"1039_CR41","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1734-1140(12)70762-4","volume":"64","author":"K Mlyniec","year":"2012","unstructured":"Mlyniec K, Nowak G (2012) Zinc deficiency induces behavioral alterations in the tail suspension test in mice. Effect of antidepressants. Pharmacological reports : PR 64(2):249\u2013255","journal-title":"Pharmacological reports : PR"},{"issue":"3","key":"1039_CR42","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.physbeh.2008.06.017","volume":"95","author":"NM Tassabehji","year":"2008","unstructured":"Tassabehji NM, Corniola RS, Almamoun A, Levenson CW (2008) Zinc deficiency induces depression-like symptoms in adult rats. Physiol Behav 95(3):365\u2013369","journal-title":"Physiol Behav"},{"issue":"1\u20133","key":"1039_CR43","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.schres.2014.02.007","volume":"154","author":"S Paulsen Bda","year":"2014","unstructured":"Paulsen Bda S, Cardoso SC, Stelling MP, Cadilhe DV, Rehen SK (2014) Valproate reverts zinc and potassium imbalance in schizophrenia-derived reprogrammed cells. Schizophr Res 154(1\u20133):30\u201335. doi:\n10.1016\/j.schres.2014.02.007","journal-title":"Schizophr Res"},{"issue":"6","key":"1039_CR44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1753-4887.1993.tb03096.x","volume":"51","author":"JL Beard","year":"1993","unstructured":"Beard JL, Connor JR, Jones BC (1993) Iron in the brain. Nutr Rev 51(6):157\u2013170","journal-title":"Nutr Rev"},{"issue":"3","key":"1039_CR45","first-page":"491","volume":"46","author":"MB Youdim","year":"2000","unstructured":"Youdim MB, Yehuda S (2000) The neurochemical basis of cognitive deficits induced by brain iron deficiency: involvement of dopamine-opiate system. Cell Mol Biol 46(3):491\u2013500","journal-title":"Cell Mol Biol"},{"issue":"7","key":"1039_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133622","volume":"10","author":"T Liu","year":"2015","unstructured":"Liu T, Lu QB, Yan L, Guo J, Feng F, Qiu J, Wang J (2015) Comparative study on serum levels of 10 trace elements in schizophrenia. PLoS One 10(7):e0133622. doi:\n10.1371\/journal.pone.0133622","journal-title":"PLoS One"},{"issue":"2","key":"1039_CR47","first-page":"40","volume":"5","author":"S Etebary","year":"2010","unstructured":"Etebary S, Nikseresht S, Sadeghipour HR, Zarrindast MR (2010) Postpartum depression and role of serum trace elements. Iranian journal of psychiatry 5(2):40\u201346","journal-title":"Iranian journal of psychiatry"},{"issue":"2","key":"1039_CR48","first-page":"97","volume":"21","author":"M Nechifor","year":"2008","unstructured":"Nechifor M (2008) Interactions between magnesium and psychotropic drugs. Magnes Res 21(2):97\u2013100","journal-title":"Magnes Res"},{"key":"1039_CR49","doi-asserted-by":"publisher","unstructured":"Wacker WE, Parisi AF (1968) Magnesium metabolism. The New England journal of medicine 278 (14):772\u2013776 concl. doi:\n10.1056\/NEJM196804042781406","DOI":"10.1056\/NEJM196804042781406"},{"issue":"1","key":"1039_CR50","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1192\/bjp.143.1.85","volume":"143","author":"JL Crammer","year":"1983","unstructured":"Crammer JL (1983) Trace metals in neuropsychiatry. British Journal of Psychiatry the Journal of Mental Science 143(1):85\u201386","journal-title":"British Journal of Psychiatry the Journal of Mental Science"},{"issue":"2","key":"1039_CR51","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1385\/BTER:98:2:109","volume":"98","author":"M Yanik","year":"2004","unstructured":"Yanik M, Kocyigit A, Tutkun H, Vural H, Herken H (2004) Plasma manganese, selenium, zinc, copper, and iron concentrations in patients with schizophrenia. Biol Trace Elem Res 98(2):109\u2013117","journal-title":"Biol Trace Elem Res"},{"issue":"86","key":"1039_CR52","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.schres.2006.05.027","volume":"86","author":"TL Wolf","year":"2006","unstructured":"Wolf TL, Kotun J, Meador-Woodruff JH (2006) Plasma copper, iron, ceruloplasmin and ferroxidase activity in schizophrenia. Schizophr Res 86(86):167\u2013171","journal-title":"Schizophr Res"}],"container-title":["Biological Trace Element Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12011-017-1039-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-017-1039-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-017-1039-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T05:43:57Z","timestamp":1514526237000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12011-017-1039-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,3]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["1039"],"URL":"https:\/\/doi.org\/10.1007\/s12011-017-1039-6","relation":{},"ISSN":["0163-4984","1559-0720"],"issn-type":[{"value":"0163-4984","type":"print"},{"value":"1559-0720","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,3]]}}}